<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; CGPDTM</title>
	<atom:link href="http://www.tapanray.in/tag/cgpdtm/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Grant of Compulsory License for Bayer’s Nexavar in India raises more questions than answers</title>
		<link>http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers</link>
		<comments>http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/#comments</comments>
		<pubDate>Mon, 26 Mar 2012 00:00:05 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[answers]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[CGPDTM]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[controller]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Grant]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[more]]></category>
		<category><![CDATA[Natco]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[questions]]></category>
		<category><![CDATA[raises]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[than]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=116</guid>
		<description><![CDATA[On March 12, 2012, the Patent Office of India, in its landmark ruling, granted its first ever Compulsory License (CL) for Bayer’s patented kidney and liver cancer drug Nexavar (Sorafenib), to the generic pharma player Natco, broadly citing the following &#8230; <a href="http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/grant-of-compulsory-license-for-bayers-nexavar-in-india-raises-more-questions-than-answers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Indian Patent offices (IPOs) have started showing improvement in their functioning; still lot of grounds to cover.</title>
		<link>http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover</link>
		<comments>http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/#comments</comments>
		<pubDate>Thu, 10 Dec 2009 01:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[CGPDTM]]></category>
		<category><![CDATA[cover]]></category>
		<category><![CDATA[functioning]]></category>
		<category><![CDATA[grounds]]></category>
		<category><![CDATA[Have]]></category>
		<category><![CDATA[improvement]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[IPO]]></category>
		<category><![CDATA[it]]></category>
		<category><![CDATA[lot]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[offices]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[showing]]></category>
		<category><![CDATA[started]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[their]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=700</guid>
		<description><![CDATA[Indian Patent offices are located, with four clearly specified jurisdictions, at New Delhi, Mumbai, Kolkata and Chennai. Since last few years enough efforts have been made towards overall capacity building initiatives, training of personnel and digitalizing the huge databank of &#8230; <a href="http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-patent-offices-ipos-have-started-showing-improvement-in-their-functioning-still-lot-of-grounds-to-cover/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Simmering discontentment in the functioning of the Indian Patent Office (IPO) – urgent need to tighten the &#8216;loose knots&#8217; in the system.</title>
		<link>http://www.tapanray.in/simmering-discontentment-in-the-functioning-of-the-indian-patent-office-ipo-urgent-need-to-tighten-the-loose-knots-in-the-system/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=simmering-discontentment-in-the-functioning-of-the-indian-patent-office-ipo-urgent-need-to-tighten-the-loose-knots-in-the-system</link>
		<comments>http://www.tapanray.in/simmering-discontentment-in-the-functioning-of-the-indian-patent-office-ipo-urgent-need-to-tighten-the-loose-knots-in-the-system/#comments</comments>
		<pubDate>Sun, 29 Mar 2009 07:00:38 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA['loose knots']]></category>
		<category><![CDATA[CGPDTM]]></category>
		<category><![CDATA[controller]]></category>
		<category><![CDATA[discontentment]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[functioning]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[IPO]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Office]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Simmering]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[tighten]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[urgent]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=929</guid>
		<description><![CDATA[Indian Patent office (IPO) though is headquartered at Kolkata, because of some unknown reason, the office of the Controller General of Patents, Designs and Trade Marks (CGPDTM)is located in Mumbai with other two offices at New Delhi and Chennai. Moreover, &#8230; <a href="http://www.tapanray.in/simmering-discontentment-in-the-functioning-of-the-indian-patent-office-ipo-urgent-need-to-tighten-the-loose-knots-in-the-system/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/simmering-discontentment-in-the-functioning-of-the-indian-patent-office-ipo-urgent-need-to-tighten-the-loose-knots-in-the-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
